Pune, India -- (SBWire) -- 06/04/2018 --Global Biomarker Technologies Market Report 2022," A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological diseases. Owing to its ability to diagnose diseases at an early stage, biomarkers are extensively used in the cancer diagnosis and treatment. The global market for biomarker discovery technologies has been segmented into omics technology (proteomics, genomics and transcriptomics), imaging technology and bioinformatics
Get a Sample PDF for Research Insights at: https://www.healthcareintelligencemarkets.com/request_sample.php?id=28541
Global biomarker technologies market is expected to reach USD +73 Billion in 2022 from USD +41 Billion in 2016, at a CAGR of +8% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022
The healthcare industry recognizes medical devices as all equipment and tools that are used either individually or together for diagnostics or therapy. This spectrum includes medical instruments, materials, devices, software, and electronic devices. The competitive landscape of the global Biomarker Technologies market is currently hinged around the top players. Most of the players are focusing heavily on enhancement of existing technologies while still dedicating a huge chunk of their resources for product innovation. The nature of the market is such that entry for newer players can be challenging, but not impossible due to the desperate need for newer technologies and innovative patents in the market.
Some of the leading vendors: Abbott Laboratories, Becton, Dickinson and Company, Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Gen-Probe Inc., F. Hoffmann La Roche Ltd., DiagnoCure Inc
Report studies the market for Biomarker Technologies from a global perspective while also analyzing it for key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. On these fronts, the market is analyzed on the basis of criteria such as market value, key segments, market volume, and distribution channels.
Avail Discount on this report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=28541
Furthermore, far-reaching investments are being made in the R&D sector to facilitate product developments and enhancements. With the arrival of new technologies on a regular basis, players are endeavoring hard to integrate the latest technology to gain a competitive edge over the rest. After studying the key players, the report concentrates on the startups impacting the growth of the market. Possible mergers and acquisitions among the startups and key establishments are identified by the report's analysts in the study. Most enterprises in the Biomarker Technologies market are presently engaged in adopting new technologies, approaches, product expansions, developments, and long-term contracts to maintain their supremacy in the global market.
Table of Content:
Chapter 1 Biomarker Technologies Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry) Is Expected to Reach USD 74.51 Billion in 2022
According to the Biomarker Technologies Market survey report, the market is expected to witness a relatively higher growth rate during the forecast period 2017-2022.